AstraZeneca reports 88% emissions cut since 2015, crediting AI for accelerating drug discovery while embedding sustainability ...

Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation July 6, 2026 9:30 AM ...

While London markets saw a general decline, EasyJet soar FTSE 250 as it said it has reached an agreement in principle for a ...

London's FTSE 100 ended lower on Monday as losses in precious metal miners and drugmakers including AstraZeneca weighed, ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

Transforming Conversations, Inspiring Action Manila, Philippines – Through the power of storytelling, ID8, Inc. is shaping ...

A month after Genentech confirmed the restructuring of its early development group, the Roche subsidiary has now disclosed ...

Nearly one in six respondents in an RTL News panel survey say they regret receiving a Covid-19 vaccine. Reasons include not ...

Stocks mixed as weak miners weigh in muted trade - Data showed the UK construction sector remained deep in contraction during ...

Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.

The British company is developing two ADCs against B7-H3 and HER2 using a novel payload it is betting can overcome resistance to other ADCs.